Announcements Trials
Browse Landscape

Status

Recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 15Observational 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Breast Neoplasms 700Neoplasms 621Prostatic Neoplasms 322Lung Neoplasms 314Colorectal Neoplasms 284Carcinoma, Non-Small-Cell Lung 260Pancreatic Neoplasms 181Carcinoma, Hepatocellular 171Stomach Neoplasms 141Multiple Myeloma 127Ovarian Neoplasms 123Melanoma 118Colonic Neoplasms 114Brain Neoplasms 111Hematologic Neoplasms 107Urinary Bladder Neoplasms 104Head and Neck Neoplasms 104Leukemia, Myeloid, Acute 102Esophageal Neoplasms 100Disease 100Uterine Cervical Neoplasms 91Liver Neoplasms 91Neoplasm Metastasis 89Lymphoma 86Rectal Neoplasms 84Precursor Cell Lymphoblastic Leukemia-Lymphoma 84Endometrial Neoplasms 79Carcinoma, Renal Cell 74Leukemia 65Recurrence 63

Interventions

Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Observational × Pancreatic Ductal Adenocarcinoma × 1 year × Clear all
NCT07226154 2025-11-21

PRECEPT

City of Hope Medical Center

Recruiting
200 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

NCT06600906 2025-11-12

Hyperpolarized 13C MRI to Predict Response in Pancreatic Cancer

University of California, San Francisco

Recruiting
70 enrolled
Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡